keyword
https://read.qxmd.com/read/38644986/clinical-efficacy-of-programmed-cell-death-ligand-1-antibody-in-treatment-of-extranodal-natural-killer-t-cell-lymphoma-with-hemophagocytic-lymphohistiocytosis
#1
Chun Li Yang, Xi Chen, Hui Jie Zhou, Wan Chun Wu, Li Qun Zou
Extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis (ENKTCL-LAHS) is a rare disease with poor prognosis. Currently, there are no well-established treatments for LAHS. Almost 50% of patients experience relapsed or refractory disease to anti-hemophagocytic lymphohistiocytosis (HLH) treatment, and the regimen for salvage therapy is limited. We report a case of ENKTCL-LAHS that was successfully treated with a programmed cell death ligand 1 (PD-L1) antibody (sugemalimab) alone and provide a literature review on existing ENKTCL-LAHS treatment options...
April 2024: Journal of Hematology (Brossard, Quebec)
https://read.qxmd.com/read/38642301/extranodal-natural-killer-t-cell-lymphoma-of-the-skeletal-muscle
#2
JOURNAL ARTICLE
Ettore di Gaeta, Floortje Verspoor, Dilara Savci, Naomi Donner, Mario Maas, Robert Hemke
This case report highlights a case of extranodal NK/T cell lymphoma initially misdiagnosed as myositis, emphasizing the appearance on both MRI and FDG PET images. The patient presented with systemic symptoms and calf muscle swelling, prompting imaging studies that revealed diffuse muscle involvement. Despite negative myositis markers and inconclusive biopsy, post-amputation findings confirmed lymphoma with EBV positivity. The appearance in both MRI and FDG PET complicated the diagnostic process, underscoring the importance of considering lymphoma in cases of muscle-related symptoms to prevent delays in appropriate management...
April 20, 2024: Skeletal Radiology
https://read.qxmd.com/read/38642276/a-case-of-methotrexate-related-lymphoproliferative-disease-showing-multiple-liver-lesions-in-a-patient-with-rheumatoid-arthritis
#3
JOURNAL ARTICLE
Yamato Nagata, Shotaro Akiba, Hidekazu Horiuchi, Kazuo Okumoto, Shigemi Hachinohe, Rintaro Ohe
A 66-year-old woman with rheumatoid arthritis (RA) who had been receiving methotrexate (MTX) for 2 years presented with tarry stools. Contrast-enhanced computed tomography (CT) of the abdomen revealed irregular wall thickening in the ileocecal region and multiple low-contrast masses in both lobes of the liver. Lower gastrointestinal endoscopy revealed a type 2 tumor in the ileocecal region with a semi-peripheral ulcer. Histological examination of liver and colon biopsies showed other iatrogenic immunodeficiency-associated lymphoproliferative disorder (Oi-LPD), diffuse large B-cell lymphoma type, with positivity for Epstein-Barr virus DNA...
April 20, 2024: Clinical Journal of Gastroenterology
https://read.qxmd.com/read/38640255/co-targeting-ebv-lytic-as-well-as-latent-cycle-antigens-increases-t-cell-potency-against-lymphoma
#4
JOURNAL ARTICLE
Sandhya Sharma, Naren U Mehta, Tim Sauer, Dirk P Dittmer, Lisa A Rollins, Cliona M Rooney
The remarkable efficacy of Epstein-Barr virus (EBV) specific T-cells for the treatment of post-transplant lymphomas (PTLD) has not been reproduced for EBV+ malignancies outside the transplant setting. This is due in part to the heterogeneous expression and poor immunogenicity of the viral antigens expressed, namely LMPs 1 and 2, EBNA1, and BARF1 (type-2 (T2) latency). However, EBV lytic cycle proteins are also expressed in certain EBV+ malignancies, and since several EBV lytic cycle proteins are abundantly expressed, have oncogenic activity, and likely contribute to malignancy, we sought and identified viral lytic-cycle transcripts in EBV+ Hodgkin's lymphoma biopsies...
April 19, 2024: Blood Advances
https://read.qxmd.com/read/38633254/case-report-ebv-related-eye-orbits-and-sinuses-lymphohistiocytic-infiltration-responsive-to-rituximab-in-a-patient-with-x-lymphoproliferative-syndrome-type-1
#5
Giuliana Giardino, Vittoria Lanni, Massimo Mascolo, Daniela Russo, Emilia Cirillo, Roberta Romano, Francesca Cillo, Laura Grilli, Maria Rosaria Prencipe, Adriana Iuliano, Giovanni Uccello, Carmela De Fusco, Giuseppe Menna, Giulia Scalia, Giuseppe Portella, Claudio Pignata
BACKGROUND AND AIMS: X lymphoproliferative syndrome type 1 (XLP1) is a rare inborn error of immunity due to mutations of SH2D1A , encoding for slam-associated protein (SAP). The clinical phenotype includes severe mononucleosis, hemophagocytic lymphohistiocytosis (HLH), and B-cell lymphomas. METHODS: We report the case of a child affected with XLP1 who presented with an incomplete HLH, triggered by Epstein-Barr virus (EBV) and treated with rituximab, involving orbits and paranasal sinuses...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38623661/clinical-features-of-non-hodgkin-lymphoma-associated-hemophagocytic-syndrome-a-retrospective-study
#6
JOURNAL ARTICLE
Chunxiu Wu, Huiyong Liu, Jianlan Chen
BACKGROUND: This study aims to improve the understanding of lymphoma-associated hemophagocytic syndrome, and find effective methods to identify and manage this fatal disease. METHODS: Patients diagnosed with non-Hodgkin lymphoma-associated hemophagocytic syndrome from January 2008 to December 2022 in our center were included. Univariate and multivariate analyses were also conducted using the Cox proportional hazards model. RESULTS: Among 26 patients, 22 patients were diagnosed with T/NK cell lymphoma, while 4 patients were diagnosed with diffuse large B cell lymphoma...
April 1, 2024: Clinical Laboratory
https://read.qxmd.com/read/38620074/sox11-expression-is-restricted-to-ebv-negative-burkitt-lymphoma-and-associates-with-molecular-genetic-features
#7
JOURNAL ARTICLE
Marta Sureda-Gómez, Ingram Iaccarino, Anna De Bolòs, Mieke Anna Meyer, Patricia Balsas, Julia Richter, Marta Leonor Rodríguez, Cristina López, Maria Carreras-Caballé, Selina Glaser, Ferran Nadeu, Pedro Jares, Maria Chiara Siciliano, Cristiana Bellan, Salvatore Tornambè, Roberto Boccacci, Guillem Clot, Lorenzo Leoncini, Elías Campo, Reiner Siebert, Virginia Amador, Wolfram Klapper
SRY-related HMG-box gene 11 (SOX11) is a transcription factor overexpressed in mantle cell lymphoma (MCL), a subset of Burkitt lymphomas (BL) and precursor lymphoid cell neoplasms but is absent in normal B-cells and other B-cell lymphomas. SOX11 has an oncogenic role in MCL but its contribution to BL pathogenesis remains uncertain. Here, we observed that the presence of Epstein-Barr virus (EBV) and SOX11 expression were mutually exclusive in BL. SOX11 expression in EBV- BL was associated with an IG∷MYC translocation generated by aberrant class switch recombination, while in EBV-/SOX11- tumors the IG∷MYC translocation was mediated by mistaken somatic hypermutations...
April 15, 2024: Blood
https://read.qxmd.com/read/38620028/latent-epstein-barr-virus-infection-collaborates-with-myc-over-expression-in-normal-human-b-cells-to-induce-burkitt-like-lymphomas-in-mice
#8
JOURNAL ARTICLE
Jillian A Bristol, Scott E Nelson, Makoto Ohashi, Alejandro Casco, Mitchell Hayes, Erik A Ranheim, Abigail S Pawelski, Deo R Singh, Daniel J Hodson, Eric C Johannsen, Shannon C Kenney
Epstein-Barr virus (EBV) is an important cause of human lymphomas, including Burkitt lymphoma (BL). EBV+ BLs are driven by Myc translocation and have stringent forms of viral latency that do not express either of the two major EBV oncoproteins, EBNA2 (which mimics Notch signaling) and LMP1 (which activates NF-κB signaling). Suppression of Myc-induced apoptosis, often through mutation of the TP53 (p53) gene or inhibition of pro-apoptotic BCL2L11 (BIM) gene expression, is required for development of Myc-driven BLs...
April 15, 2024: PLoS Pathogens
https://read.qxmd.com/read/38618451/a-rare-case-of-extranodal-natural-killer-t-cell-lymphoma-nasal-type-associated-with-hemophagocytic-lymphohistiocytosis-in-a-patient-with-recurrent-sinusitis
#9
Bryce R Christensen, Chung-Ting J Kou, Lauren E Lee
We present a rare case of hemophagocytic lymphohistiocytosis (HLH) secondary to nasal-type extranodal natural killer/T-cell lymphoma (ENKL). Nasal-type ENKL is a rare subtype of non-Hodgkin's lymphoma usually associated with Epstein-Barr virus (EBV). The patient was a 19-year-old woman who presented with facial numbness, diminished hearing, and dysgeusia. She was febrile with palatal necrosis, loss of gag reflex, and cranial nerve palsies. Labs revealed neutropenia. Broad-spectrum antimicrobials, including amphotericin, were started...
March 2024: Curēus
https://read.qxmd.com/read/38613207/expression-and-prognostic-significance-of-the-pd-1-pd-l1-pathway-in-aids-related-non-hodgkin-lymphoma
#10
JOURNAL ARTICLE
Han Zhao, Shaohang Cai, Yanhua Xiao, Muye Xia, Hongjie Chen, Zhiman Xie, Xiaoping Tang, Haolan He, Jie Peng, Juanjuan Chen
OBJECTIVE: Immune tolerance and evasion play a critical role in virus-driven malignancies. However, the phenotype and clinical significance of programmed cell death 1 (PD-1) and its ligands, PD-L1 and PD-L2, in aggressive acquired immunodeficiency syndrome (AIDS)-related non-Hodgkin lymphoma (AR-NHL) remain poorly understood, particularly in the Epstein-Barr virus (EBV)-positive subset. METHODS: We used in situ hybridization with EBV-encoded RNA (EBER) to assess the EBV status...
April 2024: Cancer Medicine
https://read.qxmd.com/read/38612754/epstein-barr-virus-latent-membrane-protein-2a-lmp2a-enhances-atp-production-in-b-cell-tumors-through-mtor-and-hif-1%C3%AE
#11
JOURNAL ARTICLE
Ryan Incrocci, Rosalinda Monroy Del Toro, Grace Devitt, Melody Salimian, Kamaljit Braich, Michelle Swanson-Mungerson
Epstein-Barr Virus (EBV) exists in a latent state in 90% of the world's population and is linked to numerous cancers, such as Burkitt's Lymphoma, Hodgkin's, and non-Hodgkin's Lymphoma. One EBV latency protein, latency membrane protein 2A (LMP2A), is expressed in multiple latency phenotypes. LMP2A signaling has been extensively studied and one target of LMP2A is the mammalian target of rapamycin (mTOR). Since mTOR has been linked to reprogramming tumor metabolism and increasing levels of hypoxia-inducible factor 1 α (HIF-1α), we hypothesized that LMP2A would increase HIF-1α levels to enhance ATP generation in B lymphoma cell lines...
April 2, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612584/molecular-features-of-hhv8-monoclonal-microlymphoma-associated-with-kaposi-sarcoma-and-multicentric-castleman-disease-in-an-hiv-negative-patient
#12
Evelina Rogges, Sabrina Pelliccia, Camilla Savio, Gianluca Lopez, Irene Della Starza, Giacinto La Verde, Arianna Di Napoli
Human herpesvirus 8 (HHV8)-associated diseases include Kaposi sarcoma (KS), multicentric Castleman disease (MCD), germinotropic lymphoproliferative disorder (GLPD), Kaposi sarcoma inflammatory cytokine syndrome (KICS), HHV8-positive diffuse large B-cell lymphoma (HHV8+ DLBCL), primary effusion lymphoma (PEL), and extra-cavitary PEL (ECPEL). We report the case of a human immunodeficiency virus (HIV)-negative male treated for cutaneous KS, who developed generalized lymphadenopathy, hepatosplenomegaly, pleural and abdominal effusions, renal insufficiency, and pancytopenia...
March 28, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38587664/role-of-plasma-ebv-dna-load-and-eber-status-on-newly-diagnosed-peripheral-t-cell-lymphoma
#13
JOURNAL ARTICLE
Jing Chen, Jie Zhou, Fei Cheng, Donghe Chen, Fangshu Guan, Enfan Zhang, Jingsong He, Zhen Cai, Yi Zhao
PURPOSE: To explore the prognostic and therapeutic role of Epstein-Barr Virus (EBV) on peripheral T-cell lymphoma (PTCL). METHODS: Totally 262 newly diagnosed PTCL patients who were hospitalized from January 2014 to December 2022 were retrospectively enrolled. Molecular analysis included 31 eligible patients. EBV-encoded RNA (EBER) presence in tumor tissue and EBV DNA levels in patients at baseline (DNA1) and after 4 cycles of chemotherapy (DNA4) were assessed. RESULTS: Our findings revealed that the EBER-positive cohort exhibited significant differences compared to counterparts in overall survival (OS, P = 0...
April 8, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/38574017/aflatoxin-b1-and-epstein-barr-virus-induced-ccl22-expression-stimulates-b-cell-infection
#14
JOURNAL ARTICLE
Mohamed Ali Maroui, Grace Akinyi Odongo, Lucia Mundo, Francesca Manara, Fabrice Mure, Floriane Fusil, Antonin Jay, Tarik Gheit, Thanos M Michailidis, Domenico Ferrara, Lorenzo Leoncini, Paul Murray, Evelyne Manet, Théophile Ohlmann, Marthe De Boevre, Sarah De Saeger, François-Loïc Cosset, Stefano Lazzi, Rosita Accardi, Zdenko Herceg, Henri Gruffat, Rita Khoueiry
Epstein-Barr Virus (EBV) infects more than 90% of the adult population worldwide. EBV infection is associated with Burkitt lymphoma (BL) though alone is not sufficient to induce carcinogenesis implying the involvement of co-factors. BL is endemic in African regions faced with mycotoxins exposure. Exposure to mycotoxins and oncogenic viruses has been shown to increase cancer risks partly through the deregulation of the immune response. A recent transcriptome profiling of B cells exposed to aflatoxin B1 (AFB1) revealed an upregulation of the Chemokine ligand 22 (CCL22) expression although the underlying mechanisms were not investigated...
April 16, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38565386/otud1-enhances-gastric-cancer-aggressiveness-by-deubiquitinating-ebv-encoded-protein-balf1-to-stabilize-the-apoptosis-inhibitor-bcl-2
#15
JOURNAL ARTICLE
Hanbin Lin, Yuting Han, Yuchao Sang, Yuecheng Wu, Mengyue Tian, Xintan Chen, Xu Lin, Xinjian Lin
The Epstein-Barr virus (EBV) is implicated in several cancers, including EBV-associated gastric cancer (EBVaGC). This study focuses on EBV-encoded BALF1 (BamH1 A fragment leftward reading frame 1), a key apoptosis regulator in EBV-related cancers, whose specific impact on EBVaGC was previously unknown. Our findings indicate that BALF1 overexpression in gastric cancer cells significantly enhances their proliferation, migration, and resistance to chemotherapy-induced apoptosis, confirming BALF1's oncogenic potential...
March 31, 2024: Biochimica et Biophysica Acta. Molecular Basis of Disease
https://read.qxmd.com/read/38563592/polymorphic-lymphoproliferative-disorder-arising-in-a-rheumatoid-arthritis-patient-presenting-as-fibrin-associated-large-b-cell-lymphoma-like-lesions-in-aortic-and-mitral-valves
#16
Hideaki Tsujii, Ryuko Nakayama, Sohei Funakoshi, Shuhei Tsuji, Hironori Haga, Kazuo Ono
We herein report a case of methotrexate-associated lymphoproliferative disorder (MTX-LPD) showing fibrin-associated large B-cell lymphoma-like heart valve lesions, and Epstein-Barr virus (EBV)-positive mucocutaneous ulcer-like cutaneous and oral mucosal lesions. MTX-LPD is a critical complication that can occur in RA patients who are treated with MTX. EBV also plays a defining or important role in LPDs. Among the sites of MTX-LPD, 40-50% occur in extranodal sites, including the gastrointestinal tract, skin, liver, lung, and kidney...
April 2, 2024: Pathology International
https://read.qxmd.com/read/38538319/extranodal-natural-killer-t-cell-lymphoma-coexisting-with-peripheral-t-cell-lymphoma-not-otherwise-specified
#17
JOURNAL ARTICLE
Kenta Hayashino, Chikamasa Yoshida, Yoshiyuki Ayata, Ryouya Yukawa, Aya Komura, Makoto Nakamura, Yusuke Meguri, Kazuhiko Yamamoto, Wakako Oda, Kenji Imajo
We report the case of a 52-year-old male who presented to our hospital with cervical lymphadenopathy. Lymph node biopsy revealed small atypical lymphoid cells positive for CD3 and CD5 and negative for CD56 and Epstein-Barr virus (EBV)-encoded small RNA (EBER) by in situ hybridization. CD4-positive cells and CD8-positive cells were mixed in almost equal numbers. He was diagnosed with peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS). The patient received one cycle of chemotherapy, resulting in severe sepsis...
2024: Journal of Clinical and Experimental Hematopathology: JCEH
https://read.qxmd.com/read/38538317/diverse-b-cell-tumors-associated-with-t-14-19-q32-q13-igh-bcl3-identified-by-g-banding-and-fluorescence-in-situ-hybridization
#18
JOURNAL ARTICLE
Hitoshi Ohno, Fumiyo Maekawa, Masahiko Hayashida, Miho Nakagawa, Katsuhiro Fukutsuka, Mitsuko Matsumura, Kayo Takeoka, Wataru Maruyama, Naoya Ukyo, Shinji Sumiyoshi, Yasuhiro Tanaka, Hironori Haga
We characterized 5 B-cell tumors carrying t(14;19)(q32;q13) that creates the IGH::BCL3 fusion gene. The patients' ages ranged between 55 and 88 years. Two patients presented with progression or recurrence of B-cell chronic lymphocytic leukemia (B-CLL)/small lymphocytic lymphoma (SLL), two with diffuse large B-cell lymphoma (DLBCL) of non-germinal center B-like phenotype, and the remaining one with composite angioimmunoblastic T-cell lymphoma and Epstein-Barr virus-positive DLBCL. The presence of t(14;19)(q32;q13) was confirmed by fluorescence in situ hybridization (FISH), showing colocalization of 3' IGH and 3' BCL3 probes on der(14)t(14;19) and 5' BCL3 and 5' IGH probes on der(19)t(14;19)...
2024: Journal of Clinical and Experimental Hematopathology: JCEH
https://read.qxmd.com/read/38537697/epstein-barr-virus-suppresses-n-6-methyladenosine-modification-of-tlr9-to-promote-immune-evasion
#19
JOURNAL ARTICLE
Xiaoyue Zhang, Zhengshuo Li, Qiu Peng, Can Liu, Yangge Wu, Yuqing Wen, Run Zheng, Chenxiao Xu, Junrui Tian, Xiang Zheng, Qun Yan, Jia Wang, Jian Ma
Epstein-Barr virus (EBV) is a human tumor virus associated with a variety of malignancies, including nasopharyngeal carcinoma, gastric cancers, and B-cell lymphomas. N6 -methyladenosine (m6 A) modifications modulate a wide range of cellular processes and participate in the regulation of virus-host cell interactions. Here, we discovered that EBV infection downregulates Toll-like receptor 9 (TLR9) m6 A modification levels and thus inhibits TLR9 expression. TLR9 has multiple m6 A modification sites. Knockdown of METTL3, an m6 A "writer", decreases TLR9 protein expression by inhibiting its mRNA stability...
March 25, 2024: Journal of Biological Chemistry
https://read.qxmd.com/read/38533980/diagnostic-utility-of-cytology-in-a-patient-with-epstein-barr-virus-positive-mucocutaneous-ulcer-in-palatine-tonsils-a-case-report
#20
JOURNAL ARTICLE
Mieko Doi, Mei Hamada, Keisuke Ishizawa, Naoki Fushimi, Yasuhiro Kase, Tetsuo Ikezono, Jun-Ichi Tamaru, Taketo Yamada
Epstein-Barr virus-positive mucocutaneous ulcer (EBVMCU) is a newly established immunodeficiency-related disease. Herein, we report a case of EBVMCU and focus on its cytological usefulness for diagnosis. An 82-year-old man manifested pharyngalgia, dysphagia, and oral pain. His medical history included rheumatoid arthritis that had been treated with methotrexate. Clinically, peritonsillar abscess was suspected, but since neoplastic lesions, including malignant lymphoma (ML), could not be excluded, a series of cytohistological examination was attempted...
March 27, 2024: Diagnostic Cytopathology
keyword
keyword
119905
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.